I have been looking into SEC filings to try and get a

New Post Public Reply Private Reply Replies (0) Message Board
DV303
I have been looking into SEC filings to try and get a glimpse into what is happening since there have been no PR's to explain. What I have found is more cause for concern than I would have expected.

I only went back to July of 2016 for this unfortunate little exercise.

Form 4 Date PR Date
07/01/16
07/14/16 - Chinese delegation meeting went well
07/27/16 - Nick K COO
07/29/16
08/03/16 08/03/16 - GC buys 279mm share
08/11/16 - Chinese want worldwide exc. lic. CSRV
08/17/16 - Fujiyan agrees to manf. engine and gen.
08/19/16 08/19/16 - # of transactions w/ largest co's in world
08/26/16 - 3 weeks until funding from China
09/02/16
09/13/16 - CA with 6th largest manf. in China
09/16/16 09/16/16 - Nick K working on funding
10/03/16

We are filing 2 Form 4's a month so we are due one more in October. We never file a Form 4 more than 2 weeks from a PR and it's not uncommon to file a Form 4 on the same day as a PR. 2 of the same day Form 4/PR's were of the vague, yet to be concluded typical PR's. 1 of the same day Form 4/PR's was GC buying 279mm shares.

My conclusion is that we release a PR in order to bring in new $ and 83.1% of that goes straight to the top.

I hope you all see something different in this than I do, this is not what I wanted to conclude. I know we have no sales, no cash and no news that ever gains traction. IF you do see something different in this than I do, please let me know so that I don't have to abandon all hope here. You all have been a positive group and everyone contributes something of value no matter how rarely they post.

Good luck in this and all other positions.

Coates International (COTE) Stock Research Links

COTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rigel Pharmaceuticals Prepares for Impact at ASH Annual Meeting

Updated Category News Views 37

Rigel Pharmaceuticals Set to Shine at ASH Annual Meeting Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a dedicated biotechnology company focused on hematologic disorders and cancer, is gearing up to present six insightful posters at the upcoming American Society of Hematology (ASH) Annual Meeting and Exposition. This prestigious event is scheduled to take place from...

Continue Reading
Life Time's Strong Q2 2026 Sparks Investor Interest

Updated Category News Views 13

Alright, let's grab a cup of Joe and talk about Life Time Group Holdings, Inc. (NYSE: LTH) and their second quarter of 2026. It’s been a hell of a ride for these folks as they sure know how to pull a rabbit out of a hat when it comes to showing profits. We're talking about a whopping 13.7% rise in revenue, hitting $866 million, and a net income rising by 40.6%. No,...

Continue Reading
Keg Royalties Income Fund Reports Strong Q2 Financial Gains

Updated Category News Views 148

Keg Royalties Income Fund Financial Summary The Keg Royalties Income Fund (TSX: KEG.UN) recently showcased its financial performance for the second quarter, highlighting significant achievements amidst dynamic market conditions. Latest Developments In a recent maneuver aimed at enhancing its financial outlook, the Fund has entered a non-binding agreement with affiliates...

Continue Reading
Exciting Updates from Portillo's Inc: Conference Participation

Updated Category News Views 169

Overview of Portillo's Management Event Portillo's, Inc. is thrilled to announce its participation in a significant event known as the Piper Sandler Growth Frontiers Conference. This is a prime opportunity for the management team to connect with investors, discussing the company’s journey and future prospects in the dining industry. Details of the Management Fireside...

Continue Reading
Oceanview Reinsurance Welcomes Muhamed Majeed as Chief Actuary

Updated Category News Views 176

Oceanview Reinsurance Welcomes New Leadership Oceanview Reinsurance Ltd., a notable name in the reinsurance sector, has recently announced the appointment of Muhamed Majeed as their new Chief Actuary. This strategic decision is set to take effect shortly, marking an exciting new chapter for the company. Expertise Driving Innovation In his pivotal role, Mr. Majeed will be...

Continue Reading